ZFIN ID: ZDB-FISH-161201-11
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.
Fish name: trappc11hi1532bTg/hi1532bTg
Genotype: trappc11hi1532bTg/hi1532bTg
Targeting Reagent: none
HUMAN DISEASE MODELED by trappc11hi1532bTg/hi1532bTg
Human Disease Conditions Citations
fatty liver disease standard conditions DeRossi et al., 2016
GENE EXPRESSION
Gene expression in trappc11hi1532bTg/hi1532bTg
RNA expression
Expressed Gene Structure Conditions Figures
agt standard conditions Fig. 5 from Fai Tse et al., 2016
alg2 standard conditions Fig. 4, Fig. 5 with image from DeRossi et al., 2016
alg5 standard conditions Fig. 4 from DeRossi et al., 2016
alg9 standard conditions Fig. 4 from DeRossi et al., 2016
apoa1a standard conditions Fig. 5 from Fai Tse et al., 2016
apoeb standard conditions Fig. 5 from Fai Tse et al., 2016
atf4a standard conditions Fig. 1 from DeRossi et al., 2016
atf6 standard conditions Fig. 1 from DeRossi et al., 2016
ddit3 standard conditions Fig. 1 from DeRossi et al., 2016
ddx5 standard conditions Fig. 5 from Fai Tse et al., 2016
dhdds standard conditions Fig. 5 with image from DeRossi et al., 2016
dnajc3a standard conditions Fig. 1 from DeRossi et al., 2016
dpagt1 standard conditions Fig. 4, Fig. 5 with image from DeRossi et al., 2016
dpm1 standard conditions Fig. 5 with image from DeRossi et al., 2016
dpm2 standard conditions Fig. 5 with image from DeRossi et al., 2016
dpm3 standard conditions Fig. 5 with image from DeRossi et al., 2016
edem1 standard conditions Fig. 1 from DeRossi et al., 2016
fabp1a standard conditions Fig. 2 from Fai Tse et al., 2016
fdft1 standard conditions Fig. 5 with image from DeRossi et al., 2016
fga standard conditions Fig. 5 from Fai Tse et al., 2016
gale standard conditions Fig. 5 from Fai Tse et al., 2016
gmds standard conditions Fig. 5 from Fai Tse et al., 2016
gmppb standard conditions Fig. 4, Fig. 5 with image from DeRossi et al., 2016
hspa5 standard conditions Fig. 1 from DeRossi et al., 2016
igfbp1a standard conditions Fig. 5 from Fai Tse et al., 2016
lect2l standard conditions Fig. 5 from Fai Tse et al., 2016
lpl standard conditions Fig. 5 from Fai Tse et al., 2016
mmp9 standard conditions Fig. 5 from Fai Tse et al., 2016
mpi standard conditions Fig. 4 from DeRossi et al., 2016
mvda standard conditions Fig. 5 with image from DeRossi et al., 2016
pitpnaa standard conditions Fig. 5 from Fai Tse et al., 2016
pmm2 standard conditions Fig. 4, Fig. 5 with image from DeRossi et al., 2016
srd5a3 standard conditions Fig. 5 with image from DeRossi et al., 2016
xbp1 standard conditions Fig. 1 from DeRossi et al., 2016
Protein expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in trappc11hi1532bTg/hi1532bTg
Phenotype Conditions Figures
liver fdft1 expression decreased amount, abnormal standard conditions Fig. 5 with image from DeRossi et al., 2016
liver dpagt1 expression increased amount, abnormal standard conditions Fig. 4, Fig. 5 with image from DeRossi et al., 2016
liver xbp1 expression increased amount, abnormal standard conditions Fig. 1 from DeRossi et al., 2016
liver alg5 expression increased amount, abnormal standard conditions Fig. 4 from DeRossi et al., 2016
liver atf4a expression increased amount, abnormal standard conditions Fig. 1 from DeRossi et al., 2016
liver pmm2 expression increased amount, abnormal standard conditions Fig. 4, Fig. 5 with image from DeRossi et al., 2016
liver dpm1 expression increased amount, abnormal standard conditions Fig. 5 with image from DeRossi et al., 2016
liver srd5a3 expression increased amount, abnormal standard conditions Fig. 5 with image from DeRossi et al., 2016
liver gmppb expression increased amount, abnormal standard conditions Fig. 4, Fig. 5 with image from DeRossi et al., 2016
liver dhdds expression increased amount, abnormal standard conditions Fig. 5 with image from DeRossi et al., 2016
liver edem1 expression increased amount, abnormal standard conditions Fig. 1 from DeRossi et al., 2016
liver dpm2 expression increased amount, abnormal standard conditions Fig. 5 with image from DeRossi et al., 2016
liver mvda expression increased amount, abnormal standard conditions Fig. 5 with image from DeRossi et al., 2016
liver alg9 expression increased amount, abnormal standard conditions Fig. 4 from DeRossi et al., 2016
liver hspa5 expression increased amount, abnormal standard conditions Fig. 1 from DeRossi et al., 2016
liver atf6 expression increased amount, abnormal standard conditions Fig. 1 from DeRossi et al., 2016
liver alg2 expression increased amount, abnormal standard conditions Fig. 4, Fig. 5 with image from DeRossi et al., 2016
liver dpm3 expression increased amount, abnormal standard conditions Fig. 5 with image from DeRossi et al., 2016
liver dnajc3a expression increased amount, abnormal standard conditions Fig. 1 from DeRossi et al., 2016
liver ddit3 expression increased amount, abnormal standard conditions Fig. 1 from DeRossi et al., 2016
liver increased size, abnormal standard conditions Fig. 2 from Fai Tse et al., 2016
liver lipid droplet increased accumulation liver, abnormal standard conditions Fig. 2 from Fai Tse et al., 2016
response to endoplasmic reticulum stress increased occurrence, abnormal chemical treatment: tunicamycin Fig. 3 with image from DeRossi et al., 2016
response to endoplasmic reticulum stress increased occurrence, abnormal standard conditions Fig. 1 from DeRossi et al., 2016
whole organism dead, abnormal chemical treatment: tunicamycin Fig. 3 with image from DeRossi et al., 2016
whole organism lpl expression decreased amount, abnormal standard conditions Fig. 5 from Fai Tse et al., 2016
whole organism igfbp1a expression decreased amount, abnormal standard conditions Fig. 5 from Fai Tse et al., 2016
whole organism decreased life span, abnormal chemical treatment: tunicamycin Fig. 3 with image from DeRossi et al., 2016
whole organism gale expression increased amount, abnormal standard conditions Fig. 5 from Fai Tse et al., 2016
whole organism ddx5 expression increased amount, abnormal standard conditions Fig. 5 from Fai Tse et al., 2016
whole organism mmp9 expression increased amount, abnormal standard conditions Fig. 5 from Fai Tse et al., 2016
whole organism agt expression increased amount, abnormal standard conditions Fig. 5 from Fai Tse et al., 2016
whole organism lect2l expression increased amount, abnormal standard conditions Fig. 5 from Fai Tse et al., 2016
whole organism pitpnaa expression increased amount, abnormal standard conditions Fig. 5 from Fai Tse et al., 2016
whole organism apoeb expression increased amount, abnormal standard conditions Fig. 5 from Fai Tse et al., 2016
whole organism fga expression increased amount, abnormal standard conditions Fig. 5 from Fai Tse et al., 2016
whole organism gmds expression increased amount, abnormal standard conditions Fig. 5 from Fai Tse et al., 2016
whole organism apoa1a expression increased amount, abnormal standard conditions Fig. 5 from Fai Tse et al., 2016

CITATIONS  (2)